Pleurodesis
8
2
2
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
12.5%
1 terminated out of 8 trials
50.0%
-36.5% vs benchmark
38%
3 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
Comparison of Talc Slurry Versus Talc Insufflation: A Study on Effectiveness, Safety, and Hospital Outcomes in Pleurodesis
Impact of Patient Position on Chemical Pleurodesis by Chest Ultrasound
Non-steroidal Anti-inflammatory Drugs in Pleurodesis
Thoracoscopic Talc Pleurodesis Versus Bleomycin -Tranxemic Acid Mixture Injection in Chest Tube in Malignant Pleural Effusion
Rapid Pleurodesis Through an Indwelling Pleural Catheter
Role of Chest Sonography in Evaluation of Pleurodesis in Patients With Malignant Pleural Effusion
Betadine Pleurodesis Via Tunneled Pleural Catheters
Improving Primary Spontaneous Pneumothorax (PSP) Treatment Techniques in VATS